PetMed Express Inc Cash Flow Conversion Efficiency
PetMed Express Inc cash flow conversion efficiency. Based on the latest financial reports, PetMed Express Inc (PETS) has a cash flow conversion efficiency ratio of -0.164x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.74 Million) by net assets ($28.94 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of PetMed Express Inc (2000–2026)
Cash flow conversion efficiency of PetMed Express Inc from 2000 to 2026. This chart illustrates how PetMed Express Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PETS share price today for real-time trading data and today's change.
PetMed Express Inc Cash Flow Conversion Ratio Explained
PetMed Express Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
PetMed Express Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PetMed Express Inc ranked by their cash flow conversion efficiency. Also see PetMed Express Inc market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Haatz Inc
KQ:066130
|
0.000x |
|
Catena Media plc
ST:CTM
|
0.055x |
|
Dalaroo Metals Ltd
AU:DAL
|
-0.433x |
|
Amanah Leasing Public Company Limited
BK:AMANAH
|
0.034x |
|
Eupe Corporation Bhd
KLSE:6815
|
0.111x |
|
Kyobo 8 Special Purpose Acquisition Company
KQ:307280
|
0.059x |
|
ENPlus Co Ltd
KO:074610
|
-0.058x |
|
Compania Introductora de Buenos Aires SA
BA:INTR
|
0.117x |
Annual Cash Flow Conversion Efficiency for PetMed Express Inc (2000–2026)
The table below shows the annual cash flow conversion efficiency of PetMed Express Inc from 2000 to 2026. Review PETS free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $28.94 Million | $-28.39 Million | -0.981x | -2298.43% |
| 2024-03-31 | $96.73 Million | $4.32 Million | 0.045x | -82.35% |
| 2023-03-31 | $109.97 Million | $27.80 Million | 0.253x | +94.34% |
| 2022-03-31 | $142.19 Million | $18.50 Million | 0.130x | -54.14% |
| 2021-03-31 | $141.28 Million | $40.08 Million | 0.284x | -5.06% |
| 2020-03-31 | $130.01 Million | $38.84 Million | 0.299x | -10.85% |
| 2019-03-31 | $134.68 Million | $45.14 Million | 0.335x | +3.77% |
| 2018-03-31 | $115.73 Million | $37.38 Million | 0.323x | -36.12% |
| 2017-03-31 | $93.37 Million | $47.20 Million | 0.506x | +99.79% |
| 2016-03-31 | $83.19 Million | $21.05 Million | 0.253x | -40.43% |
| 2015-03-31 | $75.44 Million | $32.04 Million | 0.425x | +120.84% |
| 2014-03-31 | $70.22 Million | $13.51 Million | 0.192x | -7.35% |
| 2013-03-31 | $64.01 Million | $13.29 Million | 0.208x | -17.35% |
| 2012-03-31 | $81.18 Million | $20.39 Million | 0.251x | -19.07% |
| 2011-03-31 | $97.00 Million | $30.11 Million | 0.310x | +8.58% |
| 2010-03-31 | $96.86 Million | $27.69 Million | 0.286x | +43.19% |
| 2009-03-31 | $74.97 Million | $14.97 Million | 0.200x | -30.95% |
| 2008-03-31 | $67.03 Million | $19.38 Million | 0.289x | -5.99% |
| 2007-03-31 | $53.86 Million | $16.56 Million | 0.308x | +12.63% |
| 2006-03-31 | $37.64 Million | $10.28 Million | 0.273x | -20.80% |
| 2005-03-31 | $24.22 Million | $8.35 Million | 0.345x | +336.38% |
| 2004-03-31 | $13.99 Million | $1.11 Million | 0.079x | -54.46% |
| 2003-03-31 | $5.59 Million | $970.30K | 0.173x | -42.32% |
| 2002-03-31 | $1.58 Million | $476.02K | 0.301x | +121.76% |
| 2001-03-31 | $757.29K | $-1.05 Million | -1.382x | -610.46% |
| 2000-03-31 | $1.63 Million | $-317.24K | -0.195x | -- |
About PetMed Express Inc
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional suppleme… Read more